PLO
- Product code
- PLO
- Device name
- Meningitis/Encephalitis Pathogen Multiplex Nucleic Acid Detection System
- Device class
- Class 2
- 21 CFR
- 21 CFR 866.3970
- Medical specialty
- Microbiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 1 (direct download)
- 510(k) clearances (all years, FDA)
- 4 (all years; only the last 3 years are listed here)
FDA classification definition
A meningitis/encephalitis pathogen multiplex nucleic acid detection system is a qualitative in vitro diagnostic test for the direct detection and identification of microbial-associated nucleic acids in cerebrospinal fluid. The test is indicated for individuals with signs and symptoms of meningitis or encephalitis and aids in diagnosis of agents of meningitis or encephalitis when used in conjunction with clinical and other laboratory findings.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K242256 | 2024-10-29 | QIAGEN GmbH | QIAstat-Dx Meningitis/Encephalitis (ME) Panel |
Official FDA classification page: PLO
Classification and pathway per current FDA publications. Data from openFDA (CC0).